For seven years I have been saying that my analysis of all the studies over that last 20 years show that none of the medical treatments for prostate cancer actually work.
Now, new research shows that Hormone therapy, which of course also does not work, actually increases your chances of a fatal heart attack by a massive 28%
Many men think that cutting a prostate cancer out or burning, freezing, irradiating it solves the problem.
That seems to be intuitively right but both experience and the science shows it is wrong. Men who have had their prostate removed still die of prostate cancer even though they no longer have a prostate.
Doctors say the benefit of treating prostate cancer early minimizes the risks. That sounds logical but again the science does not support it. All the research that has been done over the past 20 years shows that regardless of which conventional treatments are given (or how soon), the statistical chance of dying of prostate cancer is the same as if you have no treatment at all.
Any man that does survive after treatment would have survived without any treatment anyway. If I were you I would therefore avoid any of the conventional treatments, radiation, chemo, surgery, hormones – since none of them actually ultimately work and all of them can do you significant damage.
You may well wonder, if this is the case and if what I am telling you is right, why do doctors persist with all these treatments? The answer is that medical orthodoxy is very slow to change and perhaps also that prostate cancer is big business.
Doctors, surgeons, anesthetists, hospitals and pharmaceutical corporations do not want the flow of dollars to stop.
So what should you do? There is plenty of evidence (detailed in my book) that – if you do have prostate cancer – appropriate diet and lifestyle changes may slow the progress of what is the slowest growing cancer anyway. It should slow the progress of prostate cancer to the point where you are far more likely to die with it rather than of it. That strategy means your quality of life will improve rather than degrade plus you avoid all the risks inherent in having invasive damaging treatments.
Below is an article about the latest study:
(NaturalNews) According to the National Institutes of Health, “The appropriate treatment for prostate cancer is not clear.” However, men who have prostate cancer that has spread beyond the prostate gland or who have had a recurrence of their disease are routinely subjected to a specific treatment anyway — hormone therapy, which consists of either surgical or, more commonly, a kind of pharmacologic castration.
This shuts down the source of the male hormones testosterone and dihydrotestosterone (DHT or 5 alpha-dihydrotestosterone, a male hormone that is converted from testosterone within the prostate) believed to be fueling the cancer.
Side effects of this chemical castration can be devastating, including reduced or total lack of sexual desire, impotence, weakness and fatigue, loss of muscle mass, growth of breast tissue, hot flashes, depression and osteoporosis.
Now there’s new research showing the hormone-blocking approach used to treat men with prostate cancer has yet another dark side: It results in a dramatically increased risk of serious and often deadly heart problems.
Scientists meeting at Europe’s biggest cancer congress, dubbed ECCO 15 – ESMO 34, in Berlin recently announced the findings of the largest and most comprehensive study to date on the issue. Bottom line: the researchers said physicians should consider the risk of cardiovascular side effects when they prescribe hormone therapy for prostate cancer patients. In fact, they should refer patients to a cardiologist before starting treatment.
For the study, headed by cancer epidemiologist Mieke Van Hemelrijck of King’s College in London, the researchers looked at the records of 30,642 Swedish men with locally advanced or metastatic prostate cancer who had received hormone therapy as the primary treatment for their disease between 1997 and 2006. The men were followed for about three years and the scientists studied their risk of developing ischemic heart disease, heart attacks, arrhythmia, heart failure requiring hospitalization, and death from heart disease. Then they compared the rates of heart problems among these prostate cancer patients with those of people in the general Swedish population.
“We found that prostate cancer patients treated with hormone therapy had an elevated risk of developing all of the individual types of heart problems and that they were more likely than normal to die from those causes,” Van Hemelrijck said.
She added another worrisome point: the heart problems started within only a few months after the men began their hormone therapy. In all, prostate cancer patients treated with hormone therapy had a 24 percent increased risk of a non-fatal heart attack, a 19 percent increased risk of arrhythmia, a 31 percent increased risk of ischemic heart disease and a 26 percent increased risk of heart failure. The risk of a fatal heart attack was increased by 28 percent, the risk of dying from heart disease soared by 21 percent, the risk of heart failure death was increased by 26 percent and the risk of a fatal arrhythmia was increased by 5 percent.
Men taking anti-androgen therapy (which block testosterone from binding to the prostate cells but still allows some testosterone to circulate in the body) had a somewhat lower risk of heart problems than those on gonadotropin releasing hormone agonist therapy which is a stronger testosterone blocker.
The association with heart risk when the testicles were removed was also extra high, similar to those taking the gonadotropin-releasing hormone agonist therapy. But, despite all the dangerous side effects and risks associated with depriving a man of his male hormones, this kind of therapy must be worth it because it cures some men of advanced disease, right? Wrong. In fact, it is not a cure at all.
Hormone therapy is medically useless “Hormone therapy does not cure prostate cancer,” the American Cancer Society states on its web site. And a study published in the journal Reviews in Urology by New York University School of Medicine urologists Mark A Perlmutter and Herbert Lepor concluded: “Ultimately, men (with advanced prostate cancer) will develop disease that is refractory to all hormonal manipulations. This is termed androgen-independent prostate cancer.”